Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT2080222104
JPRN-jRCT2080222104
Unknown
Phase 3

A phase III study of M801801 in plaque psoriasis patients

Maruho Co.,Ltd.0 sitesJune 10, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPlaque psoriasis

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Plaque psoriasis
Sponsor
Maruho Co.,Ltd.
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 10, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients diagnosed with plaque psoriasis

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Phase 3
M518101 phase III study in plaque psoriasis patientsPlaque psoriasis
JPRN-jRCT2080222894Maruho Co.,Ltd.
Unknown
Phase 2
M518101 phase 2b study in plaque psoriasis patients - comparison study 2Plaque psoriasis
JPRN-jRCT2080221434Maruho Co.,Ltd.
Unknown
Phase 2
M518101 phase 2b study in plaque psoriasis patients - comparison study 1
JPRN-jRCT2080221433Maruho Co.,Ltd.
Unknown
Phase 2
M518101 phase 2b study in plaque psoriasis patients - comparison study 3
JPRN-jRCT2080222091Maruho Co.,Ltd.
Completed
Phase 3
Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque PsoriasisPsoriasis
NCT01878461Maruho North America Inc.542